USA – Alone in a bathroom:

The fear and uncertainty of a post-Roe medication abortion

By Caroline Kitchener
April 11, 2024

Angel tucked two white pills into each side of her mouth, bracing herself as they began to dissolve. Her deepest fears and anxieties took over.

Angel had wanted to talk to a doctor before she took the pills to end her pregnancy, worried about how they might interact with medication she took for her heart condition. But in her home state of Oklahoma, where almost all abortions are banned, that wasn’t an option.

Continued: https://www.washingtonpost.com/politics/interactive/2024/abortion-pill-experience-stories/

USA – How the abortion pill case at the supreme court could undo the FDA

The medical industry watches with trepidation as mifepristone case could have huge consequences for drug regulation

Jessica Glenza in New York
Mon 25 Mar 2024

A supreme court case about one little pill – mifepristone – has the medical and pharmaceutical world on edge. … Despite a more than 20-year track record of safe real-world use, backed up by more than 100 peer-reviewed studies, a group of anti-abortion doctors is seeking to roll back US Food and Drug Administration (FDA) decisions that changed and relaxed some prescribing rules.

If the doctors succeed, despite contested and in some cases now-retracted evidence of harm, the case could reshape abortion access in the US and have enormous and unpredictable consequences for how drugs are prescribed, regulated and developed.

Continued: https://www.theguardian.com/us-news/2024/mar/25/abortion-pill-case-fda

25.03.2024

Food and Drug Administration

Juan Hincapie-Castillo

The Disastrous Potential of the Texas Abortion-Pill Ruling

A nationwide ban on mifepristone would further erode doctors’ ability to provide—or learn how to provide—lifesaving care.

By Isaac Chotiner
April 11, 2023

Last week, two federal judges issued conflicting rulings on the abortion drug mifepristone, setting the stage for a clash that is likely to end up in the Supreme Court. First, a judge in Texas ruled that mifepristone would be banned nationwide in seven days. Then, a judge in Washington ordered the F.D.A. not to make any changes to the availability of the drug, which the agency approved for use more than two decades ago and which has an extensive safety record. While the legal process unfolds, abortion providers and health professionals are caught in limbo, exacerbating the challenges they have faced since last year’s Dobbs decision.

I recently spoke by phone with Jody Steinauer, the director of the Bixby Center for Global Reproductive Health at the University of California, San Francisco, to better understand how abortion care changed after Dobbs and what a ban on mifepristone would mean for women’s health care. Our conversation, edited for length and clarity, is below.

Continued: https://www.newyorker.com/news/q-and-a/the-disastrous-potential-of-the-texas-abortion-pill-ruling

11.04.2023

Interviews/Podcasts

Accreditation Council for Graduate Medical Education

Bixby Center for Global Reproductive Health

Jody Steinauer

mifepristone

miscarriage management

misoprostol-only abortions

U.S.: This New Site Aims to Make It Safer to Have an Abortion at Home

This New Site Aims to Make It Safer to Have an Abortion at Home
"If we truly believe in women’s self-determination, they should also have a choice in how."

By Jill Filipovic
Apr 27, 2017

No one knows exactly how many women in the United States induce their own abortions every year, but we do know that, despite abortion being legal, a number of women take matters into their own hands. In the United States, women self-managing their own abortions — whether because they can’t access or afford a legal abortion in a clinic, because of feelings of fear or shame, or because they simply prefer the privacy of ending a pregnancy themselves — have long relied on word of mouth, Google, or their own instincts to figure out what to do and whether something has gone wrong.

That’s what Women Help Women wants to change. The organization just launched a new website that offers personalized information for women seeking to end early pregnancies with misoprostol, an abortion-inducing medication.

Continued at source: Cosmopolitan: http://www.cosmopolitan.com/politics/a9560329/self-managed-home-abortion-pill/

27.04.2017